Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Emerging Infectious Diseases|June 23, 2004
Reference group choice and antibiotic resistance outcomesKeith S Kaye, John J Engemann, Essy Mozaffari, et al.
Infectious Disease Clinics of North America|August 17, 2004
Pathogens resistant to antimicrobial agents: epidemiology, molecular mechanisms, and clinical managementKeith S Kaye, John J Engemann, Henry S Fraimow, et al.
Infection Control and Hospital Epidemiology|June 11, 2004
Control of nosocomial acquisition of vancomycin-resistant Enterococcus through active surveillance of hemodialysis patientsR Neal Axon, John J Engemann, James Butcher, et al.
Infection Control and Hospital Epidemiology|July 10, 2004
Surgical-site infection due to Staphylococcus aureus among elderly patients: mortality, duration of hospitalization, and costSarah A McGarry, John J Engemann, Kenneth Schmader, et al.
American Journal of Respiratory and Critical Care Medicine|November 26, 2002
Safety of 2 months of rifampin and pyrazinamide for treatment of latent tuberculosisJason E Stout, John J Engemann, Allen C Cheng, et al.
Antimicrobial Agents and Chemotherapy|May 26, 2006
Differential effects of levofloxacin and ciprofloxacin on the risk for isolation of quinolone-resistant Pseudomonas aeruginosaKeith S Kaye, Zeina A Kanafani, Ashley E Dodds, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2006
Predictors of mortality in patients with bloodstream infection due to ceftazidime-resistant Klebsiella pneumoniaeDeverick J Anderson, John J Engemann, Lizzie J Harrell, et al.
Infection Control and Hospital Epidemiology|March 15, 2006
Favorable impact of an infection control network on nosocomial infection rates in community hospitalsKeith S Kaye, John J Engemann, Evelyn M Fulmer, et al.
Pharmacotherapy|April 29, 2009
Therapeutic drug monitoring of antimycobacterial drugs in patients with both tuberculosis and advanced human immunodeficiency virus infectionDavid P Holland, Carol D Hamilton, Amy C Weintrob, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 12, 2020
Social Disadvantage, Politics, and Severe Acute Respiratory Syndrome Coronavirus 2 Trends: A County-level Analysis of United States DataAhmad Mourad, Nicholas A Turner, Arthur W Baker, et al.
Pageof 3